Where diverse expertise creates fresh perspectives
We are geneticists, immunologists, statisticians, systems biologists, data scientists, programmers, and software engineers passionate about advancing therapeutic development through biomarkers.
Everyday QuartzBio helps our clients generate value from large-scale heterogeneous biomedical data—managing, analyzing, exploring, interpreting, and reporting—to create informed, sound, and actionable insights.
Where diverse expertise creates fresh perspectives
We are geneticists, immunologists, statisticians, systems biologists, data scientists, programmers, and software engineers passionate about advancing therapeutic development through biomarkers.
Everyday QuartzBio helps our clients generate value from large-scale heterogeneous biomedical data—managing, analyzing, exploring, interpreting, and reporting—to create informed, sound, and actionable insights.
Our global solution
Our global solution
About Precision for Medicine
Precision for Medicine is the first biomarker-driven clinical development organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments more precisely and effectively. Precision applies novel biomarker approaches to clinical research, leveraging the latest advancements in science and technology. The Precision for Medicine QuartzBio multiomic data integration and informatics platform enables life sciences companies to discover hidden subgroups of patients who will most benefit from a given therapy, delivering the means for truly personalized medicine. Precision for Medicine is part of Precision Medicine Group, with over 2,000 employees in 35 locations in the US, Canada, and Europe.
News & Insights
More information and news about QuartzBio and Precision for Medicine
AAIC 2020 Poster:
A Genetic Enrichment Strategy for Delay of Onset of Alzheimer’s Disease Clinical Trials
SITC 2020 Poster: Reverse causal inferencing on molecular data from lung adenocarcinoma patients reveals a stem cell-like molecular subtype associated with pack year history
Press Release: QuartzBio™, part of Precision for Medicine, Expands Computational Biology and Launches Boston Office
Featured Content
News & Insights
More information and news about QuartzBio and Precision for Medicine
AAIC 2020 Poster:
A Genetic Enrichment Strategy for Delay of Onset of Alzheimer’s Disease Clinical Trials
SITC 2020 Poster: Reverse causal inferencing on molecular data from lung adenocarcinoma patients reveals a stem cell-like molecular subtype associated with pack year history
Press Release: QuartzBio™, part of Precision for Medicine, Expands Computational Biology and Launches Boston Office
Featured Content
Partner with us to harness
the power of your data